 29.2
21.3
18.6
15.5
13.7
TRADING PROFIT*
£29.2m
2013 2014 2015 2016 2017
279.6
246.7
236.0
226.1
208.8
2013 2014 2015 2016 2017
GROUP REVENUE
£279.6m
ADJUSTED EARNINGS PER SHARE**
 14.8p
14.8
10.6
9.1
7.2
6.0
2013 2014 2015 2016 2017
21.8
9.8
13.7
11.2
9.6
PROFIT BEFORE TAX
£21.8m
2013 2014 2015 2016 2017
FINANCIAL HIGHLIGHTS
• Scapa achieved significant goals this 
year – Healthcare exceeded £100m in 
sales, Industrial achieved double-digit 
margins, and the Company achieved 
£500m market capitalisation
• Revenue, trading profit and margins 
grew for the seventh consecutive 
year, showing the benefit of a 
consistent and well executed strategy
• Revenue increased to £279.6m, 
helped by currency tailwinds and the 
acquisition of EuroMed
• Trading profit increased to £29.2m 
with both businesses contributing well
• Margins increased to 10.4% as the 
Industrial ROCE strategy continues 
to deliver 
• This strong performance results in 
an adjusted EPS increase of 39.6%, 
supporting an increase in the 
dividend to 2.0p from 1.75p
* Operating profit before amortisation of intangible assets, exceptional items and pension administration costs
** Adjusted for exceptional items, amortisation of intangible assets, pension administration costs, non-cash interest, and the tax thereon
STRATEGIC REPORT
SCAPA GROUP PLC ANNUAL REPORT AND ACCOUNTS 2017 1
